Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03046524 · ClinicalTrials.gov registry record
Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior
A clinical trial of Parathyroid Carcinoma and Parathyroid Neoplasm, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 100
- Enrollment target
- 1
- Study location
NCT03046524 is a study of Parathyroid Carcinoma and Parathyroid Neoplasm that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03046524, a study of Parathyroid Carcinoma and Parathyroid Neoplasm, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
Objectives: 1. Identify the clinical characteristics of parathyroid (PTH) cancer and PTH atypical neoplasms 2. Investigate if PTH carcinoma and atypical neoplasm present a biological behaviour and have a different impact on the health of the patients
Conditions Studied
Interventions
- OTHER Chart Review
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2015-10-06 |
| Est. Completion | 2017-10-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03046524
The ClinicalTrials.gov registry entry for NCT03046524 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Parathyroid Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Chart Review is the first listed.
NCT03046524 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT03046524 about?
NCT03046524 is a clinical study titled "Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior". Objectives: 1. Identify the clinical characteristics of parathyroid (PTH) cancer and PTH atypical neoplasms 2. Investigate if PTH carcinoma and atypical neoplasm present a biological behaviour and have a different impact on the health of the patients
What is the current status of trial NCT03046524?
This trial is currently completed. The enrollment target is 100 participants. The study started on 2015-10-06. Estimated completion is 2017-10-16.
What conditions does trial NCT03046524 study?
This clinical trial studies the following conditions: Parathyroid Carcinoma, Parathyroid Neoplasm.
What interventions are being tested in trial NCT03046524?
The interventions under investigation include: Chart Review (OTHER).
Who is sponsoring clinical trial NCT03046524?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03046524 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.